2022-12-29から1日間の記事一覧
" Phase I studies of BI 1015550, a preferential PDE4B inhibitor, in healthy males and 2 patients with idiopathic pulmonary fibrosis 3 TM Maher, C Schlecker, D Luedtke… - ERJ Open …, 2022 - Eur Respiratory Soc … in patients with idiopathic …
" Epidemiology and real-life experience in progressive pulmonary fibrosis C Valenzuela, V Cottin - Current opinion in pulmonary medicine, 2022 … : Idiopathic pulmonary fibrosis (IPF), characterized by relentless disease progression from th…